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ABSTRACT 
Diagnostic medical microbiology laboratories detect and identify pathogens in submitted 
specimens. The techniques used should maximise the detection of pathogens (sensitivity) 
while minimising the number of tests for their detection (efficiency). To achieve the best 
compromise between sensitivity and efficiency, it is necessary to have information on both 
the relative prevalence and clinical importance of various pathogens within the relevant 
community, and the relative efficiency of various detection techniques. 
This investigation had three primary objectives: to establish what pathogens were 
associated with community-acquired gastrointestinal symptoms in the Eastern Bay of 
Plenty, and the incidence and relative importance of each; to compare the merits of 
various methods for detecting these pathogens (in those cases where more than one 
method was available): and to collect data from patients so as to identify potential sources 
and/or risk factors for infection. 
997 faecal specimens from 716 episodes of illness were tested over a one year period. 
Patients completed a questionnaire on symptoms, and food and environmental exposures. 
Using one or more standard techniques, the specimens were tested for bacteria and 
parasites which may cause gastroenteritis. Specimens from young children were also 
tested for the presence of rotavirus. 
The incidence rates of the various pathogens, expressed as a rate per 100 OOO persons per 
year, were as follows: Blastocystis hominis, 358; Campylobacter species, 208: Giardia 
lamblia, 158; Yersinia species, 87; Cryptosporidium parvum, 67; Salmonella species, 62; 
Aeromonas species, 62; Dien/amoeba fragilis, 29; Plesiomonas shigelloides, 21 ; 
Escherichia coli (E coli) 0157, 4; Vibrio cholerae non-01, non-0139, 4; and Shigella 
species< 4. 
Faecal specimen macroscopic form, microscopic findings, season. and patient age showed 
little correlation with the presence of specific pathogens. Consequently the tests selected 
for the detection of pathogens in faeces should not be based on any of the above 
parameters. Furthermore, the symptoms associated with parasitic and bacterial infections 
were similar, so it is not possible to select the appropriate tests on this basis. The 
presence of rotavirus in patients older than five years was not investigated so incidence 
in the general population can not be calculated. A study of all age groups for the 
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presence of this organism would be appropriate. 
From the above findings, and an evaluation of the literature, it is recommended that all 
specimens should be examined for the following organisms and, on the basis of our 
observations, the most cost-effective method is shown in brackets: Salmonella (selenite 
enrichment subcultured to xylose lysine desoxycholate agar); Shigella (none were detected, 
so a cost-effective medium could not be detennined), Campylobacter (5% sheep blood 
agar supplemented with 32 mg/1 cefoperazone); Yersinia (Yersinia selective agar (YSA), 
plus selenite enrichment subcultured to YSA); Giardia lamblia (detection of antigen); 
Cryptosporidium parvum (detection of antigen). 
While routine testing for E coli O 157 is not recommended, laboratories should have the 
capability totest for this pathogen if a patient presents with haemolytic uraemic syndrome, 
thrombotic thrombocytopenic purpura or unexplained bloody diarrhoea. Likewise, routine 
culture for Vibrio species is not recommended; however, laboratories should test 
specimens using thiosulphate citrate bilesalt sucrose agar if the requesting clinician 
suspects cholera, or the patient has a recent history of shellfish consumption. A trichome 
stain for Dientamoeba .fragilis is recommended for patients with chronic gastrointestinal 
symptoms who are to be investigated for neoplastic and other non-infectious conditions. 
Pathogenic parasites other than those noted above were not detected. However, since such 
organisms are isolated in New Zealand, usually in association with overseas travel or 
institutionalisation, it is recommended that a trichrome stain and a faecal concentration 
technique should be performed on specimens_ from all cases of gastroenteritis ~ho have 
recently travelled overseas or who are institutionalised. Close liaison between the 
laboratory and the clinician is essential to ensure appropriate selective testing for these 
less common pathogens. 
The presence of Blastocystis hominis and Aeromonads should be reported, but the report 
should note that their pathogenicity is uncertain. Dientamoeba fragilis and Plesiomonas 
shigelloides are probably pathogenic, but further work is needed to clarify this point. 
Correlation of data from the questionnaires and the laboratory findings identified the 
following risk factors: (the relative risk, 95% confidence interval and p-value are shown 
in the brackets). Campylobacter species: consumption of unpasteurised milk (4.67, 2.39 -
9.11, p = <0.001); Salmonella species: overseas travel (7.20, 1.67 - 20.9, p = 0.040), 
eating a barbecued meal (4.55, 1.37 - 15.12, p = 0.026), eating shellfish (3.80, 1.18 -
12.21, p = 0.032); Yersinia species: consumption of water from a home supply (3.46, 1.32 
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- 9.10, p = 0.016), handling cattle (4.88, 1.73 - 13.76, p = 0.008), handling sheep (14.80, 
4.93 - 44.46, p = 0.001); Giardia lamb/ia: consumption of unpasteurised milk (3.93, 1.63 -
9.46, p = 0.011), attendance at a day care centre (2.70, 1.17 - 6.27, p = 0.033), handling 
cattle (3.39, 1.59 - 7.22, p = 0.005), handling horses (5.27, 1.85 - 14.97, p = 0.002); 
Cryptosporidium parvum: consumption of water from a home supply ( 5 .08, 1. 88 - 13. 71, 
p = 0.002), consumption of unboiled water from a natural waterway (3.97, 1.29 - 12.24, 
p = 0.031 ), attendance at a day care centre (3 .30, 1.06 - 10.22, p = 0.054), handling cattle 
(5.41, 1.88 - 15.58, p = 0.006), owning a cat (4.50, 1.02 - 19.91, p = 0.029); Plesiomonas 
shigelloides: eating shellfish (13.67, 1.44 - 130.13, p = 0.020); and Dientamoebafragilis: 
consumption of unboiled water from a natural waterway (7.46, 1.71 - 32.48, p = 0.019). 
The risk factors suggest the value of the following precautions to prevent gastrointestinal 
infection: maintaining a high standard of both personal hygiene (particularly in the rural 
environment) and environmental hygiene in areas that food is prepared; avoiding 
consumption of untreated water or unpasteurised milk; cooking animal-derived food 
thoroughly - especially barbecued food and shellfish; and washing hands thoroughly after 
animal contact. Persons with diarrhoeal symptoms should take particular care with 
personal hygiene. Those travelling overseas should be conscious of the risk associated 
with the consumption of food and water which is not properly cooked or treated. 
These findings should assist New Zealand laboratories to optimise their approach to the 
detection of faecal p~thogens and shoul~ also assist in formulating policy for prevention 
of infection by enteric pathogens. 
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